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Eccrine Differentiation in Basal Cell Carcinoma
Peter J. Heenan and Matthew S. Bogle
Eccrine differentiation according to histologic and immuno-histochemical criteria was demonstrated in 16 of 66 basal cell
carcinomas. The possibility of origin of these neoplasms from the eccrine duct, including the acrosyringium, is discussed in
relation to the differences in site distribution and etiology between basal cell carcinoma and squamous cell carcinoma.
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Eccrine differentiation is generally regarded as a rare feature of basal cell
carcinoma (BCC) [1,2]. In our experience, however, in a population in which
BCC is extremely common [3], these tumors often show features suggestive of
eccrine differentiation. This study was undertaken, therefore, as an attempt to
assess the frequency of eccrine differentiation in a small series of BCC and to
consider its implications.
MATERIALS AND METHODS
Sixty-six consecutive excision specimens of BCC from one pathology laboratory were
examined by routine histologic methods [hematoxylin and eosin, periodic acid Schiff
(PAS) with and without diastase digestion] on formalin-fixed, paraffin-embedded material.
Immunohistochemical staining was performed by an avidin-biotin technique [4] for
carcinoembryonic antigen (CEA) (Dako, titer 1:200) and for cytokeratins detected by the
monoclonal antibodies AE1 and AE3 (Hybritech; titer 1:200) and CAM 5.2 (Becton-
Dickinson; titer 1:20). The criteria used for eccrine differentiation were the following.
1. (a) Alveolar collections of cells with vacuolated cytoplasm within
aggregates of typical BCC, forming tubular structures similar to the intra-
epidermal portion of embryonic eccrine ducts [2]. (b) the presence in the
tumor of simple tubular structures similar in morphology to eccrine ducts
and lined by flattened eosinophilic (cuticular) epithelium and sur-
rounded by atypical basaloid cells.
2. CEA positivity in the lining cuticular epithelium, in the vacuolated cells,
and in the contents, when present, of the lumina [5,6].
3. positivity for AE1 and AE3 in ductal structures in the tumors in a pattern
similar to that seen in normal eccrine ducts and negative staining for
CAM 5.2, also as seen in eccrine ducts [6].
4. PAS positivity after diastase digestion in the contents of the lumina and in
the vacuolated epithelium.
The patients consisted of 42 men and 24 women, ranging in age from 27 to 86 years;
35 tumors occurred on the head and neck, 22 on the trunk, and nine on the limbs.
RESULTS
Sixteen of the 66 neoplasms met criteria, 1, 2, and 3 for eccrine differentiation
(Figs 1–4). Staining for CEA was seen mainly in linear patterns on the surfaces
of cells in the alveolar structures, with less intense cytoplasmic positivity. The
pattern for AE1 and AE3 was very similar to that for CEA, mainly in linear
luminal and cell-surface distribution, with more diffuse cytoplasmic staining.
PAS positivity after diastase digestion was found in the ductal structures in 15
of the 16 neoplasms, although often in only sparse distribution. The tumors
were all of typical solid and adenocystic patterns with peripheral palisading,
the common feature of BCC, which might be an indicator of eccrine or
follicular differentiation because palisading is a prominent feature of both
follicular and eccrine germs [7]. Eight of these tumors came from the head and
neck, six from the trunk, and two from the limbs.
DISCUSSION
The presence of ductal structures in BCC can be interpreted in
several ways.
Entrapment of Segments of Normal Eccrine Ducts in the Tumor This is a
common occurrence in BCC, but although the walls of entrapped ducts are
frequently hyperplastic, the structures are otherwise still identifiable as normal
ducts. The ductal structures that we interpreted as being intrinsic parts of the
neoplasms were composed of atypical epithelium merging with the
surrounding tumor. The structures were far more numerous than could be
explained by entrapment of normal ducts, and they were distributed
throughout the lobules of tumors. In particular, the alveolar collections of
vacuolated cells were easily distinguishable from the more sharply defined
normal ductal segments.
Ductal Differentiation in BCC Might Be of Apocrine Type Apocrine and
eccrine ducts are indistinguishable from one another [2]; these tumors,
however, came from anatomic sites in which apocrine glands are usually
absent or scarce, and no apocrine glands could be seen in the sections,
whereas eccrine glands were plentiful. Apocrine ducts have been reported to
show positivity for CAM 5.2 [6], but all BCC showed negative results with this
reagent in our study.
BCC with Sebaceous Differentiation Might Contain Ductal Structures No
evidence of sebaceous differentiation, however, was found in these tumors.
The alveolar collections of cells showing positivity for CEA in these tumors
had relatively large, often single vacuoles and peripheral, flattened nuclei,
unlike sebaceous cells with their multiple smaller vacuoles and central,
crenated nuclei.
Sebaceous glands in our material were CEA negative except for small foci
of interstitial or peripheral positivity.
The Presence of These Ductal Structures Might Represent True Eccrine
Differentiation Although the features described in these tumors are not
specific for eccrine differentiation, the combination of histologic and
immunohistochemical features similar to those of normal eccrine ducts and
common neoplasms of eccrine ducts, such as syringoma (Fig 5), in both their
cytologic detail and pattern seems to provide strong evidence for eccrine
differentiation.
Squamoid eddies in these tumors, some containing central necrotic
foci, also stained positively for AE1, AE3, and CEA. Concentric layers of
squamoid cells also surrounded alveolar and ductal structures, but the
immunostaining in these tubular foci was sharp and linear, in contrast with
the more diffuse positivity of the squamoid cells and the irregular, granular
staining of necrotic debris. The association of these squamoid eddies with
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Figure 1. a) Basal cell carcinoma with solid and ‘‘adenoid’’ components, b) At higher power, the neoplasm contains alveolar clusters of cells with clear
cytoplasm (large arrow), small duct-like structures (small arrow), and squamoid eddies (asterisk).
Figure 2. a) Immunostaining for CEA on the surface of cells in the alveolar clusters, on the luminal surfaces of duct-like structures, in the surrounding cells, and
in the squamoid eddies, b) Immunostaining for CEA in the acrosyringium and superficial dermal eccrine duct.
Figure 3. a) Immunostaining for AEl and AE3 in ductal and alveolar structures and in squamoid eddies, b) Immunostaining for AEl and AE3 in the acrosyringium
and superficial dermal eccrine duct.
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ductal structures and their immunohistochemical staining suggest therefore
that they also might be indicators of eccrine rather than epidermal or follicular
differentiation.
If the features described in these tumors are accurate indicators of eccrine
differentiation, it appears that two main implications should be considered:
(1) eccrine differentiation is a manifestation of mixed differentiation in
neoplasms of multipotent stem-cell origin [8], derived from either the
epidermis or adnexal epithelium; and (2) eccrine differentiation might
indicate that the neoplasms originate directly from the eccrine duct, including
the acrosyringium.
Mehregan [9] has suggested that the origin of cutaneous adnexal tumors
from the cells of pre-existing structures should be considered as an alternative
to the pluripotent stem-cell theory [8]. The possibility of the origin of BCC,
itself an adnexal neoplasm according to some authorities [10,11], from the
eccrine duct might also be reviewed on the basis of clinical and histologic
observations, as proposed by Mehregan for adnexal tumors [9]. Accordingly,
points in favor of origin from eccrine ducts of these BCC showing eccrine
differentiation are the following.
1. The presence of ductal structures within the tumors showing evidence of
eccrine differentiation, as described above.
2. Frequent continuity of the BCC with eccrine ducts, including
the acrosyringia [7] and foci of in situ BCC in the walls of eccrineducts
(Fig 6).
3. The sharing of common features by eccrine neoplasms and BCC. Eccrine
neoplasms, benign and malignant, show positivity for CEA [12,13]
in a pattern similar to that seen in these BCC. Eccrine neoplasms
frequently also contain squamous eddies or whorls [14,15] similar to
the concentric collections of squamoid cells surrounding the ductal
structures seen in BCC in this study (Fig 1). The presence of these
squamous eddies, also described in BCC as being CEA positive by Kidd
et al [16], might be another manifestation therefore of eccrine
differentiation rather than an indicator of follicular differentiation [17].
If this is true, eccrine differentiation in this group of tumors might be
more prevalent than indicated only by those 16 BCC containing obvious
duct for mation because squamous eddies were common in the 50 other
neoplasms that were devoid of ductal structures. Furthermore, typical
components of both BCC and eccrine ductal carcinoma coexist in
some tumors wherein solid groups of uniform basaloid cells with
peripheral palisading, indistinguishable from BCC, are present in the
superficial dermis and at the dermoepidermal junction, whereas the
more deeply infiltrating component consists of typical syringomatous
carcinoma (Fig 7).
With regard to the remaining BCC in this series, which showed no
obvious adnexal differentiation and were composed mainly of solid groups
of atypical basaloid cells, it might be postulated that these tumors are also
of eccrine origin, representing the least differentiated of this group of
neoplasms.
Although the recognition of eccrine differentiation in BCC might be
regarded as merely an exercise in morphologic classification, eccrine origin of
these tumors would have more important biologic implications. BCC is
usually described as occurring predominantly on the exposed skin in similar
distribution to squamous cell carcinoma (SCC), arising as an apparently direct
result of long-term exposure to UV light [18]. In a recent survey of non-
melanocytic skin cancers in the coastal town of Geraldton in Western
Australia, however, very marked differences in anatomic site distribution
between BCC and SCC were demonstrated [3]. A much larger proportion of
BCC than SCC occurred on the trunk, whereas BCC were uncommon on the
dorsum of the hand and forearm, which were common sites of SCC. BCC also
does not originate from the mucosal surface of the lip, a common site for SCC.
Figure 4. Immunostaining for CAM 5.2 in the secretory segments of eccrine
glands. The eccrine ducts and the BCC (arrow) show no staining.
Figure 5. Immunostaining of syringoma for a) CEA; positive staining of
luminal contents and of lining epithelium, b) AE1 and AE3. More diffuse
positivity for these antibodies in the cytoplasm of the ductal epithelium, with
an accentuated linear pattern on the luminal surface.
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These differences in site distribution between BCC and SCC invite the
following inferences.
1. Some or all BCC might be causally related more to intermit tent than
continuous exposure to UV light [19], as are the commonest forms of
cutaneous malignant melanoma [20,21], which share some of the site
distribution characteristics of BCC.
2. Some or all BCC might be derived from different cells from those that give
rise to SCC, and the response to UV light of these cells might be more
complex than that of the progenitors of SCC.
The acrosyringium, as a biologic and anatomic unit distinct from the
intervening epidermis [22,23], appears to react differently to UV light
exposure, as shown frequently by the preservation of intact acrosyringia
surrounded by atypical epithelium in solar keratoses and SCC (Fig 8), perhaps
due to the marked pigmentation of the peripheral basal cells of the
acrosyringium [2]. The origin of some BCC from the acrosyringium and
dermal eccrine duct therefore might explain, at least in part, the difference
Figure 6. a) BCC involving acrosyringium. b) BCC involving superficial
dermal eccrine duct producing an in situ carcinoma pattern.
Figure 7. a) Features of BCC (arrow) and eccrine ductal carcinoma (asterisk)
in the same tumor, b) Typical BCC in the superficial dermis and at the
dermoepidermal junction, c) Infiltrating ductal carcinoma with syringomatous
features.
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between the relationship of BCC and SCC to sunlight exposure, as suggested
by their anatomic site distributions.
We thank Dr. B.K. Armstrong for his helpful comments and Mrs. S.G.Jones for typing the
manuscript.
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Figure 8. Intact acrosyringia surrounded by atypical squamous epithelium in
solar keratosis.
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